Literature DB >> 8517134

Indirect immunofluorescence in the investigation of rapidly progressive sensorineural hearing loss and Menière's disease.

P Salomon1, R Charachon, J M Lejeune.   

Abstract

Being aware of the conservation of antigenicity, we performed indirect immunofluorescence on non fixed non decalcified frozen hamster's cochlea. Once killed, the heads of the hamsters were immediately dipped into liquid nitrogen and then stored at -20 degrees C until cutting. The sections were done at the same temperature, with Tissue-Tek embedding the heads to avoid breaking, using a sharp tungsten knife. The immunofluorescence itself was performed with the sera of the patients which were revealed through donkey fluorescein-conjugated antiserum to human immunoglobulins. For counterstaining, we used Evans blue. Twenty patients with rapidly progressive sensorineural hearing loss (according to the clinical criteria of MacCabe) and 6 with Menière's disease were tested. Five had a specific fluorescence on the stria vascularis. A correlation with the lymphocyte transformation test on human inner ear antigen has been found (p = 0.055).

Entities:  

Mesh:

Year:  1993        PMID: 8517134     DOI: 10.3109/00016489309135816

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Antibodies to inner ear antigens in Meniere's disease.

Authors:  L Riente; F Bongiorni; A Nacci; P Migliorini; G Segnini; A Delle Sedie; F Ursino; S Tommasi; B Fattori
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

2.  Vertigo, hearing loss, and tinnitus.

Authors:  S A Raza; J J Phillipps
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

3.  Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss.

Authors:  A E Tebo; P Szankasi; T A Hillman; C M Litwin; H R Hill
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.